Search research articles
Contact Us
Filters
Showing results (611-620 of 619) with videos related to
Page
of 62
Sort By:
You have reached the last page of results.
This site can display upto 619 results.
Signal Transduction and Targeted Therapy
|
March 17, 2023
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, et al.
Ebiomedicine
|
April 26, 2023
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial
Yu-Zhou Gui, Xue-Ning Li, Jing-Xin Li, et al.
Cancer Cell
|
October 15, 2024
A prospective study of neoadjuvant pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma: The Keystone-001 trial
Xiaobin Shang, Yongjie Xie, Jinpu Yu, et al.
Journal of the National Cancer Center
|
July 22, 2024
Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016
Xin Wang, Fei Liang, Xiaomin Wang, et al.
Molecular Cancer
|
May 15, 2025
Perioperative nivolumab and chemotherapy in locally advanced squamous cell carcinoma of the oesophagus: a randomized multicentre phase 2 study with circulating tumor DNA dynamics monitoring
Heng Jiao, Siyun Lin, Jianmin Gu, et al.
Liver Cancer
|
August 21, 2023
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study
Bin Xu, San-Yuan Dong, Xue-Li Bai, et al.
Nature Medicine
|
May 13, 2024
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
Yue Zeng, Chun-Hong Hu, Yi-Zheng Li, et al.
The New England Journal of Medicine
|
March 4, 2026
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
Guo-Ming Shi, Xiao-Yong Huang, Fei Liang, et al.
Cancer Cell
|
December 5, 2025
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial
Lei Fan, Wen-Juan Zhang, Hui-Ping Li, et al.
Page
of 62
Search research articles
Search
Showing results (611-620 of 619) with videos related to
Sort By:
Page
of 62
You have reached the last page of results.
This site can display upto 619 results.
Signal Transduction and Targeted Therapy
|
March 17, 2023
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, et al.
Ebiomedicine
|
April 26, 2023
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial
Yu-Zhou Gui, Xue-Ning Li, Jing-Xin Li, et al.
Cancer Cell
|
October 15, 2024
A prospective study of neoadjuvant pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma: The Keystone-001 trial
Xiaobin Shang, Yongjie Xie, Jinpu Yu, et al.
Journal of the National Cancer Center
|
July 22, 2024
Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016
Xin Wang, Fei Liang, Xiaomin Wang, et al.
Molecular Cancer
|
May 15, 2025
Perioperative nivolumab and chemotherapy in locally advanced squamous cell carcinoma of the oesophagus: a randomized multicentre phase 2 study with circulating tumor DNA dynamics monitoring
Heng Jiao, Siyun Lin, Jianmin Gu, et al.
Liver Cancer
|
August 21, 2023
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study
Bin Xu, San-Yuan Dong, Xue-Li Bai, et al.
Nature Medicine
|
May 13, 2024
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
Yue Zeng, Chun-Hong Hu, Yi-Zheng Li, et al.
The New England Journal of Medicine
|
March 4, 2026
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
Guo-Ming Shi, Xiao-Yong Huang, Fei Liang, et al.
Cancer Cell
|
December 5, 2025
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial
Lei Fan, Wen-Juan Zhang, Hui-Ping Li, et al.
Page
of 62